Keyword: Kemal Malik


Bayer in Push to Lift US Profile

06.04.2016 - With its expanded consumer healthcare portfolio in mind following the $14 billion acquisition of the relevant Merck & Co business in 2004, Bayer is striving to lift its profile in...

Markets & Companies

The Future Lies in the Genome

07.10.2015 - Kemal Malik, board member for innovation at the German Bayer Group, sees many similarities in the genetic system of humans, animals and plants. This opens the door for synergies in...


Kemal Malik appointed Bayer AG Board of Management member with responsibility for Innovation

20.12.2013 - The Supervisory Board of Bayer AG appointed Kemal Malik (51) to the Board of Management of Bayer AG effective February 1, 2014. Malik has been a member of the Bayer HealthCare...